Protocol No.

163189 (LYL845-101)

Principal Investigator

Hu-Lieskovan, Siwen

Phase

I

Age Group

Adult

ClinicalTrials.Gov

NCT05573035 (Click to jump to clinicaltrials.gov)

Title

Phase I Study to Assess the Safety and Efficacy of LYL845 in Adults with Relapsed and/or Refractory Metastatic or Locally Advanced Melanoma and Selected Solid Tumor Malignancies

Objective